These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24027429)

  • 1. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.
    Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML
    Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
    Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
    Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tpl2 is a key mediator of arsenite-induced signal transduction.
    Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
    Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
    Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
    Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1α (Chemokine Stromal Cell-Derived Factor-α) Axis Suppresses Diabetic Retinopathy.
    Lai DW; Lin KH; Sheu WH; Lee MR; Chen CY; Lee WJ; Hung YW; Shen CC; Chung TJ; Liu SH; Sheu ML
    Circ Res; 2017 Sep; 121(6):e37-e52. PubMed ID: 28724746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-C Motif Chemokine 8 promotes angiogenesis in vascular endothelial cells.
    Xue S; Tang H; Zhao G; Shen Y; Yang EY; Fu W; Shi Z; Tang X; Guo D
    Vascular; 2021 Jun; 29(3):429-441. PubMed ID: 32972333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β-activated kinase 1 regulates angiogenesis via AMP-activated protein kinase-α1 and redox balance in endothelial cells.
    Zippel N; Malik RA; Frömel T; Popp R; Bess E; Strilic B; Wettschureck N; Fleming I; Fisslthaler B
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2792-9. PubMed ID: 24072697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion tunes inflammatory TPL2 kinase signal transduction.
    Vougioukalaki M; Georgila K; Athanasiadis EI; Eliopoulos AG
    Cell Mol Life Sci; 2022 Feb; 79(3):156. PubMed ID: 35218437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL1 stimulates decidual angiogenesis via the VEGF-A pathway during the first trimester of pregnancy.
    Ma C; Liu G; Liu W; Xu W; Li H; Piao S; Sui Y; Feng W
    Mol Cell Biochem; 2021 Aug; 476(8):2989-2998. PubMed ID: 33770315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Tpl2 (Tumor Progression Locus 2) Inhibition on Diabetic Vasculopathy Through the Blockage of the Inflammasome Complex.
    Sheu WH; Lin KH; Wang JS; Lai DW; Lee WJ; Lin FY; Chen PH; Chen CH; Yeh HY; Wu SM; Shen CC; Lee MR; Liu SH; Sheu ML
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e46-e62. PubMed ID: 33176446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities.
    Awazu Y; Nakamura K; Mizutani A; Kakoi Y; Iwata H; Yamasaki S; Miyamoto N; Imamura S; Miki H; Hori A
    Mol Cancer Ther; 2013 Jun; 12(6):913-24. PubMed ID: 23548264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
    Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
    PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study.
    Shi CS; Kuo KL; Chen MS; Chow PM; Liu SH; Chang YW; Lin WC; Liao SM; Hsu CH; Hsu FS; Chang HC; Huang KH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.